Reply to correspondence on “Cardiovascular risk in chronic hepatitis B patients treated with tenofovir disoproxil fumarate or tenofovir alafenamide”
- Author:
Pin-Nan CHENG
1
;
Ming-Lung YU
Author Information
- Publication Type:Reply to Correspondence
- From:Clinical and Molecular Hepatology 2024;30(4):1031-1032
- CountryRepublic of Korea
- Language:English
